These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
| |
||
(Address of principal executive offices) |
(Zip Code) |
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
| Emerging growth company | ||||||
Page |
||||||
| Part I - Financial Information |
||||||
| Item 1. |
5 |
|||||
| Item 2. |
19 |
|||||
| Item 3. |
24 |
|||||
| Item 4. |
25 |
|||||
| Part II - Other Information |
||||||
| Item 1. |
25 |
|||||
| Item 1A. |
25 |
|||||
| Item 2. |
25 |
|||||
| Item 3. |
25 |
|||||
| Item 4. |
25 |
|||||
| Item 5. |
25 |
|||||
| Item 6. |
25 |
|||||
26 |
||||||
• |
Our limited operating history in the borates industry and no revenue from our proposed mining operations at our properties; |
• |
Our need for substantial additional financing to execute our business plan and our ability to access capital and the financial markets; |
• |
Our status as an exploration stage company with no known mineral reserves and the inherent uncertainty in estimates of mineral resources; |
• |
Our lack of history in mineral production and the significant risks associated with achieving our downstream processing ambitions; |
• |
We have incurred significant net operating losses to date and we anticipate incurring continued losses for the foreseeable future; |
• |
Risks and uncertainties relating to the development of the Fort Cady project (“Fort Cady” or the “Project”); |
• |
Risks related to our ability to prepare and update further technical and economic analysis of the Project, and the timing thereof; |
• |
Our dependence on a single mining project; |
• |
Risks related to our ability to achieve and maintain profitability and to develop positive cash flow from our operating activities; |
• |
Risks related to the demand for end use applications that require borates and related minerals and compounds that we expect to produce; |
• |
Our long-term success is dependent on our ability to enter into and deliver product under supply agreements; |
• |
Risks related to estimates of our total addressable market; |
• |
The costs and availability of natural gas and electricity; |
• |
Uncertain global economic conditions and the impact this may have on our business and plans; |
• |
Risks associated with our ongoing investment in the Project; |
• |
Risks associated with the required infrastructure at the Project site; |
• |
Risks related to the titles of our mineral property interests and related water rights; |
• |
Any restrictions on our ability to obtain, recycle and dispose of water on site; |
• |
Risks related to the portion of the Project that we lease from a third party; |
• |
Risks related to land use restrictions on our properties; |
• |
Risks related to volatility in prices or demand for borates and other minerals; |
• |
Fluctuations in the U.S. dollar relative to other currencies; |
• |
Risks related to mineral exploration and development; |
• |
Risks related to equipment shortages and supply chain disruptions; |
• |
Risks associated with any of our suppliers not implementing ethical business practices in compliance with applicable laws and regulations; |
• |
Competition from new or current competitors in the mineral exploration and mining industry; |
• |
Risks associated with consolidation in the markets in which we operate and expect to operate; |
• |
Risks related to compliance with environmental and regulatory requirements; |
• |
Risks and costs associated with the generation and disposal of hazardous waste; |
• |
Risks related to reclamation requirements; |
• |
Risks related to climate change; |
• |
Risks related to our ability to acquire and maintain necessary mining licenses, permits or access rights; |
• |
Litigation risk; |
• |
Risks related to our main operations being located in the State of California; |
• |
Risks related to our engagement with local communities and other stakeholders; |
• |
Risks relating to our investment in the Salt Wells Projects located in Nevada; |
• |
Our dependence on key management and third parties; |
• |
Risks related to potential acquisitions, joint ventures and other investments; |
• |
Risks related to public health threats, including the novel coronavirus, that may cause disruptions to our operations or may have a material adverse effect on our development plans and financial results; |
• |
Information technology risks; |
• |
Risks and costs relating to the Reorganization, including failure to achieve the expected benefits of the Reorganization; |
• |
Risks related to the possible dilution of our Common Stock; |
• |
Risks related to our stock price and trading volume volatility; |
• |
Risks relating to the development of an active trading market for our Common Stock; |
• |
Risks related to our status as an emerging growth company; |
• |
Risks related to technology systems and security breaches; |
• |
A shortage of skilled technicians and engineers; |
• |
Unanticipated costs or delays associated with our Small-Scale Boron Facility; |
• |
Risks related to technology systems and security breaches; |
• |
Risks associated with outside events outside of our control, such as natural disasters, climate change, wars, or health epidemics or pandemics; |
• |
Uncertainties related to the COVID-19 pandemic; |
• |
Our increased costs as a result of being a U.S. listed public company; and |
• |
Strategic actions, including acquisitions and dispositions of investments, including but not limited to integrations of acquiring investments. |
| MARCH 31 | JUNE 30, | |||||||
| 2022 | 2021 | |||||||
ASSETS |
||||||||
CURRENT ASSETS: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Prepaid expenses and other current assets |
||||||||
Total current assets |
||||||||
MINERAL RIGHTS AND PROPERTIES, Net |
||||||||
CONSTRUCTION IN PROGRESS |
||||||||
PROPERTIES, PLANT AND EQUIPMENT, Net |
||||||||
RECLAMATION BOND DEPOSIT |
||||||||
RIGHT OF USE ASSETS |
||||||||
TOTAL ASSETS |
$ | $ | ||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
CURRENT LIABILITIES: |
||||||||
Accounts payable and accrued liabilities |
$ | $ | ||||||
Lease liabilities, current |
||||||||
Total current liabilities |
||||||||
LONG-TERM DEBT |
||||||||
LEASE LIABILITIES |
||||||||
ACCRUED RECLAMATION LIABILITIES |
||||||||
Total liabilities |
||||||||
COMMITMENTS AND CONTINGENCIES (Note 10) |
||||||||
STOCKHOLDERS’ EQUITY |
||||||||
Preferred stock, $ g |
$ |
$ |
||||||
Common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated other comprehensive income (loss): |
||||||||
Reporting currency translation |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total stockholders’ equity |
||||||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
$ | $ | ||||||
| FOR THE THREE MONTHS ENDED MARCH 31 |
FOR THE NINE MONTHS ENDED MARCH 31 |
|||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||
| COST AND EXPENSES |
||||||||||||||||
| Project expenses |
$ | $ | $ | $ | ||||||||||||
| General and administrative |
||||||||||||||||
| Depreciation and amortization expense |
||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Total cost and expenses |
||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| LOSS FROM OPERATIONS |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| |
|
|
|
|
|
|
|
|||||||||
| NON-OPERATING INCOME (EXPENSE) |
||||||||||||||||
| Other income |
||||||||||||||||
| Interest income |
||||||||||||||||
| Interest expense |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Net foreign exchange gain (loss) |
( |
) | ( |
) | ( |
) | ||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Total non-operating income (expense) |
( |
) | ( |
) | ||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| NET LOSS |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| OTHER COMPREHENSIVE LOSS (INCOME) |
||||||||||||||||
| Reporting currency translation |
( |
) | ( |
) | ||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| NET LOSS AND OTHER COMPREHENSIVE LOSS |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
| |
|
|
|
|
|
|
|
|||||||||
| Net loss per common share – basic and diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
| |
|
|
|
|
|
|
|
|||||||||
| Weighted average common shares outstanding — basic and diluted |
||||||||||||||||
| FOR THE NINE MONTHS ENDED MARCH 31 |
||||||||
| 2022 | 2021 | |||||||
| Cash Flows From Operating Activities: |
||||||||
| Net loss |
$ | ( |
) | $ | ( |
) | ||
| Adjustments to reconcile net loss to net cash used by operating activities: |
||||||||
| Depreciation and amortization |
||||||||
| Interest earned on reclamation bond |
( |
) | ( |
) | ||||
| Share based compensation |
||||||||
| Common stock issued for consulting fees |
||||||||
| Accretion of reclamation liability |
||||||||
| Net foreign exchange (gain) loss |
( |
) | ||||||
| Change in: |
||||||||
| Prepaid expenses and other current assets |
( |
) | ||||||
| Accounts payable and accrued liabilities |
||||||||
| |
|
|
|
|||||
| Net cash used by operating activities |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Cash Flows From Investing Activities: |
||||||||
| Construction in progress |
( |
) | ( |
) | ||||
| Mineral rights and properties |
( |
) | ( |
) | ||||
| Properties, plant and equipment |
( |
) | ( |
) | ||||
| Reclamation bonds |
( |
) | ||||||
| |
|
|
|
|||||
| Net cash used by investing activities |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Cash Flows From Financing Activities: |
||||||||
| Payments on note payable |
( |
) | ( |
) | ||||
| Proceeds from issuance of common stock |
||||||||
| Proceeds from exercise of stock options |
||||||||
| Share offering costs |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Net cash provided by financing activities |
||||||||
| |
|
|
|
|||||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
||||||||
| EFFECT OF EXCHANGE RATE FLUCTUATION ON CASH |
( |
) | ||||||
| CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD |
||||||||
| |
|
|
|
|||||
| CASH AND CASH EQUIVALENTS AT END OF PERIOD |
$ | $ | ||||||
| |
|
|
|
|||||
| NONCASH INVESTING AND FINANCING ACTIVITIES |
||||||||
| Accounts payable change related to construction in progress additions |
$ | $ | ||||||
| Recognition of operating lease liabilities and right of use assets |
||||||||
| Construction in progress transferred to properties, plant and equipment |
||||||||
| Equipment acquired with notes payable |
||||||||
Three and Nine Months Ended March 31, 2022 |
||||||||||||||||||||||||
Common Stock |
Additional Paid-in Capital |
Accumulated Other Comprehensive Income (Loss) |
Accumulated Deficit |
Total Stockholders’ Equity |
||||||||||||||||||||
Shares |
Amount |
|||||||||||||||||||||||
| Balance at July 1, 2021 |
$ | $ | |
$ | $ | ( |
) | $ | ||||||||||||||||
| Shares issued for: |
||||||||||||||||||||||||
| Exercise of stock options |
— | — | ||||||||||||||||||||||
| Consulting fees |
— | — | ||||||||||||||||||||||
| Share based compensation |
— | — | — | — | ||||||||||||||||||||
| Net loss |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||
| Other comprehensive (loss) |
— | — | — | ( |
) | — | ( |
) | ||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Balance at September 30, 2021 |
( |
) | ( |
) | ||||||||||||||||||||
| Shares issued for: |
||||||||||||||||||||||||
| Cash |
— | — | ||||||||||||||||||||||
| Exercise of stock options |
— | — | ||||||||||||||||||||||
| Consulting fees |
— | — | ||||||||||||||||||||||
| Shares issuance costs |
— | — | ( |
) | — | — | ( |
) | ||||||||||||||||
| Share based compensation |
— | — | — | — | ||||||||||||||||||||
| Net loss |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||
| Other comprehensive income |
— | — | — | — | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Balance at December 31, 2021 |
( |
) | ||||||||||||||||||||||
| Shares issued for: |
||||||||||||||||||||||||
| Exercise of stock options |
— | — | ||||||||||||||||||||||
| Consulting fees |
— | — | ||||||||||||||||||||||
| Share based compensation |
— | — | — | — | ||||||||||||||||||||
| Net loss |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||
| Other comprehensive income |
— | — | — | ( |
) | — | ( |
) | ||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Balance at March 31, 202 2 |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Three and Nine Months Ended March 31, 2021 | ||||||||||||||||||||||||
Accumulated |
||||||||||||||||||||||||
Additional |
Other |
Total |
||||||||||||||||||||||
Common Stock |
Paid-in |
Comprehensive |
Accumulated |
Stockholders’ |
||||||||||||||||||||
Shares |
Amount |
Capital |
Income (Loss) |
Deficit |
Equity |
|||||||||||||||||||
| Balance at July 1, 2020 |
$ | $ | $ | ( |
) | $ | ( |
$ | |
|||||||||||||||
| Shares issued for: |
||||||||||||||||||||||||
| Exercise of stock options |
— | — | ||||||||||||||||||||||
| Consulting fees |
— | — | ||||||||||||||||||||||
| Shares issuance costs |
— | — | ( |
) | — | — | ( |
) | ||||||||||||||||
| Share based compensation |
— | — | — | — | ||||||||||||||||||||
| Net loss |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||
| Other comprehensive income |
— | — | — | — | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Balance at September 30, 2020 |
$ | ( |
) | |||||||||||||||||||||
| Shares issued for: |
||||||||||||||||||||||||
| Exercise of stock options |
— | — | ||||||||||||||||||||||
| Share based compensation |
— | — | — | — | ||||||||||||||||||||
| Net loss |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||
| Other comprehensive income |
— | — | — | — | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Balance at December 31, 2020 |
$ | ( |
) | |||||||||||||||||||||
| Shares issued for: |
||||||||||||||||||||||||
| Cash |
— | — | ||||||||||||||||||||||
| Exercise of stock options |
— | — | ||||||||||||||||||||||
| Shares issuance costs |
— | — | ( |
) | — | — | ( |
) | ||||||||||||||||
| Share based compensation |
— | — | — | — | ||||||||||||||||||||
| Net loss |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||
| Other comprehensive income |
— | — | — | — | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Balance at March 31, 2021 |
$ | $ | $ | $ | ( |
$ | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| March 31, | June 30, | |||||||
| 2022 | 2021 | |||||||
Mineral properties – Fort Cady Borate Project |
$ | |
$ | |
||||
Hydrology wells |
||||||||
Mineral interest – Elementis lease |
||||||||
Asset retirement cost, net of accumulated amortization of $ |
||||||||
| $ | |
$ | |
|||||
March 31, |
June 30, |
|||||||
2022 |
2021 |
|||||||
Crystallizer |
$ | $ | ||||||
Engineering services |
||||||||
Injection and recovery wells |
||||||||
Electric infrastructure |
||||||||
Filter system |
||||||||
Centrifuge system |
||||||||
Air compression |
||||||||
Boiler |
||||||||
Conveyor system |
||||||||
Scrubbers |
||||||||
Water treatment |
||||||||
Pumps |
||||||||
Other |
||||||||
Total Construction in Progress |
$ | $ | ||||||
March 31, |
June 30, |
|||||||
2022 |
2021 |
|||||||
Land |
$ | $ | ||||||
Buildings |
||||||||
Vehicles |
||||||||
Plant and equipment |
||||||||
Less accumulated depreciation |
( |
) | ( |
) | ||||
Properties, plant and equipment, net |
$ | $ | ||||||
March 31, |
June 30, |
|||||||
2022 |
2021 |
|||||||
| Accrued reclamation costs |
$ | $ | ||||||
| Asset retirement obligation |
||||||||
| |
|
|
|
|||||
| $ | $ | |||||||
| |
|
|
|
|||||
2022 |
||||
| Retirement obligation asset — beginning of period |
$ | |||
| Obligation incurred during the period |
||||
| Accretion |
||||
| |
|
|||
| Retirement obligation asset — end of period |
$ | |||
| |
|
|||
| For the year ending June 30, 2022 (April 1 – June 30) |
$ | |||
| 2023 |
||||
| 2024 |
||||
| 2025 |
||||
| |
|
|||
| Total |
||||
| Less imputed interest |
( |
) | ||
| |
|
|||
| Net lease liability |
||||
| Current portion |
||||
| |
|
|||
| Long-term portion |
$ | |||
| |
|
| • | Issued |
| • | Issued |
| • | Issued |
Average for nine-month periods ended March 31, | ||||
2022 |
2021 | |||
| Exercise price |
$ |
$ | ||
| Share price |
$ |
$ | ||
| Volatility |
||||
| Expected term in years |
||||
| Risk free interest rate |
||||
| Dividend rate |
||||
2022 |
2021 |
|||||||||||||||
Number of Options |
Weighted Averaged Exercise Price |
Number of Options |
Weighted Averaged Exercise Price |
|||||||||||||
| Outstanding at beginning of the period |
$ | $ | ||||||||||||||
| Granted |
$ | $ | ||||||||||||||
| Exercised |
( |
) | $ | ( |
) | $ | ||||||||||
| Expired/forfeited |
( |
) | $ | ( |
) | $ | ||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Outstanding at end of period |
$ | $ | ||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Vested at the end of the period |
$ | $ | ||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||
| Hurdle stock price |
$ | $ | $ | $ | ||||||||||||
| Volatility |
% | % | % | % | ||||||||||||
| Expected term in years |
||||||||||||||||
| Risk-free interest rate |
% | % | % | % | ||||||||||||
| Expected dividend yield |
% | % | % | % | ||||||||||||
| Estimated fair value per share |
$ | $ | $ | $ |
| FOR THE THREE MONTHS | FOR THE NINE MONTHS | |||||||||||||||||||||||||||||||
| ENDED MARCH 31 | Change | ENDED MARCH 31 | Change | |||||||||||||||||||||||||||||
| 2022 | 2021 | $ | % | 2022 | 2021 | $ | % | |||||||||||||||||||||||||
| COST AND EXPENSES |
||||||||||||||||||||||||||||||||
| Project expenses |
$ | 1,972,536 | $ | 2,045,719 | $ | (73,183 | ) | (3.6 | %) | $ | 9,782,791 | $ | 3,424,419 | $ | 6,358,372 | 185.7 | % | |||||||||||||||
| General and administrative |
30,983,504 | 1,828,279 | 29,155,225 | * | 44,616,803 | 8,121,310 | 36,495,493 | * | ||||||||||||||||||||||||
| Depreciation and amortization expense |
36,063 | 6,081 | 29,982 | * | 76,249 | 15,344 | 60,905 | * | ||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Total cost and expenses |
32,992,103 | 3,880,079 | 29,112,024 | * | 54,475,843 | 11,561,073 | 42,914,770 | * | ||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| LOSS FROM OPERATIONS |
(32,992,103 | ) | (3,880,079 | ) | (29,112,024 | ) | * | (54,475,843 | ) | (11,561,073 | ) | (42,914,770 | ) | * | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| NON-OPERATING INCOME (EXPENSE) |
||||||||||||||||||||||||||||||||
| Other income |
27,477 | 1,459 | 26,018 | * | 37,843 | 3,530 | 34,313 | * | ||||||||||||||||||||||||
| Interest income |
1,748 | 333 | 1,415 | * | 3,552 | 1,447 | 2,105 | 145.5 | % | |||||||||||||||||||||||
| Interest expense |
(3,275 | ) | (468 | ) | (2,807 | ) | * | (7,958 | ) | (2,117 | ) | (5,841 | ) | (275.9 | %) | |||||||||||||||||
| Net foreign exchange gain (loss) |
(3,469 | ) | (47,245 | ) | 43,776 | (92.7 | %) | 965,180 | (2,060,234 | ) | 3,025,414 | * | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| Total non-operating income (expense) |
22,481 | (45,921 | ) | 68,402 | 204.3 | % | 998,617 | (2,057,374 | ) | 1,617,765 | * | |||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| NET LOSS |
(32,969,622 | ) | (3,926,000 | ) | (29,043,622 | ) | * | (53,477,226 | ) | (13,618,447 | ) | (39,858,779 | ) | 292.7 | % | |||||||||||||||||
| OTHER COMPREHENSIVE LOSS (INCOME) |
||||||||||||||||||||||||||||||||
| Reporting currency translation |
338,592 | (84,626 | ) | 423,218 | * | 1,168,480 | (2,466,052 | ) | 3,634,532 | * | ||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| NET LOSS AND OTHER COMPREHENSIVE LOSS |
$ | (33,308,214 | ) | $ | (3,841,374 | ) | $ | (29,466,840 | ) | * | $ | (54,645,706 | ) | $ | (11,152,395 | ) | $ | (43,493,311 | ) | * | ||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
| * | Represents a percent change of greater than +/- 300%. |
| Nine Months Ended March 31, | ||||||||
| 2022 | 2021 | |||||||
| Summary of Cash Flows: |
||||||||
| Net cash used by operating activities |
$ | (23,389,986 | ) | $ | (6,107,237 | ) | ||
| Net cash used by investing activities |
$ | (4,609,538 | ) | $ | (9,985,955 | ) | ||
| Net cash provided by financing activities |
$ | 28,531,845 | $ | 34,197,918 | ||||
| Net increase (decrease) in cash and cash equivalents |
$ | 329,021 | $ | 18,510,544 | ||||
| Beginning cash and cash equivalents |
$ | 40,811,269 | $ | 26,639,953 | ||||
| Ending cash and cash equivalents |
$ | 41,140,290 | $ | 45,150,497 | ||||
Item 4. |
Controls and Procedures. |
| Exhibit Number |
Description | |
| 31.1* | Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 31.2* | Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 32.1* | Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 32.2* | Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 101.INS* | XBRL Instance Document - embedded within the Inline XBRL document | |
| 101.SCH* | XBRL Taxonomy Extension Schema Document | |
| 101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document | |
| 101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document | |
| 101.LAB* | XBRL Taxonomy Extension Label Linkbase Document | |
| 101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document | |
| 104* | Cover page Interactive Data file (formatted as Inline XBRL and contained in Exhibit 101). | |
| * | Filed herewith. |
| 5E Advanced Materials, Inc. | ||||
| (Registrant) | ||||
| Date: May 12, 2022 | By: | /s/ Paul Weibel | ||
| Paul Weibel | ||||
| Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) | ||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|